A Phase II Trial of S-1 and Oxaliplatin in Patients with Metastatic Breast Cancer Previously Treated with Anthracycline and Taxane (KCSG-BR07-03).

Cancer research and treatment(2023)

引用 1|浏览72
暂无评分
摘要
This phase II study showed that SOX regimen is a reasonable option in metastatic breast cancer previously treated with anthracyclines and taxanes.
更多
查看译文
关键词
Breast neoplasms,Drug therapy,Oxaliplatin,Phase II trial,S-1
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要